In the spirit of true partnership, Cetero Research recently held two Scientific Exchange symposia during the 2007 Annual AAPS Meeting & Exposition.
These symposia were a way of providing a forum and opportunity to benefit from our collective expertise. Our 24 years of experience in clinical research and development has taught us many things—most importantly that collaboration, information and education enable our industry to grow which benefits the scientific community as a whole.
If you were unable to attend the symposia, we have complimentary podcasts available for each topic. Please click here to download Cetero Research’s 2007 Scientific Exchange symposia.
For those interested in TQT topics…
For those interested in Dermatology and Transdermal topics…
“Practical Considerations for Design
and Implementation of Successful
TQT Trials”
“Cadaver Skin Permeation Testing: A Critical Step in Your Drug Development”
Dr. Jeffrey Litwin
eResearchTechnology, Inc.
• Healthy Normal vs. Patient
volunteers (specifically regarding oncology compounds)
• Sample size determination and
number of cohorts
Dr. Lawrence Satin
Cardiocore
• Number and timing of readings
• Choosing the right dose
Dr. Alan Copa
Cetero
• The clinical operational execution
approach of TQT trials
Open exchange between speakers, panel and guests
Paul Lehman
Cetero
“The Cadaver Skin Permeation Assay: A Valid Surrogate for BA/BE Assessment”
Fundamentals of the cadaver skin assay
focusing on in-vitro/in-vivo correlation.
Critique/Conclusion
Brief critique by Dr. Annette Bunge (CSM)
and Dr. Gerald B. Kasting (UC)
Dr. Tom Franz
Cetero
“Role of Cadaver Skin Permeation Assay in New and Generic Drug Development”
The Critical Path Initiative and using the
assay in the drug development process.
Critique/Conclusion
Brief critique by Dr. Annette Bunge (CSM)
and Dr. Gerald B. Kasting (UC)